Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36

Journal of Lipid Research

Volumn 40, Issue 5, 1999, Pages 830-838

  Han, Jihong ^a   Hajjar, David P ^a   Tauras, James M ^a   Nicholson, Andrew C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CD36; Cholesterol macrophage; Cyclodextrin; Scavenger receptor

Indexed keywords

BETA CYCLODEXTRIN; CD36 ANTIGEN; CHOLESTEROL; DACTINOMYCIN; IODINE 125; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; SCAVENGER RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ISOTOPE LABELING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD36; BASE SEQUENCE; BETA-CYCLODEXTRINS; CELL LINE; CHOLESTEROL; CYCLODEXTRINS; DNA, COMPLEMENTARY; DOWN-REGULATION; HALF-LIFE; LIPOPROTEINS, LDL; MACROPHAGES; MICE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; RNA, MESSENGER; UP-REGULATION;

EID: 0001506684     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Steinberg, D. 1987. Lipoproteins and the pathogenesis of atherosclerosis. Circulation. 76: 508-514.
2. Steinberg, D., S. Parthasarathy, T. Carew, J. Khoo, and J. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein which increase its atherogenicity. N. Engl. J. Med. 320: 915-919.
3. Gown, A., T. Tsukada, and R. Ross. 1986. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125: 191-207.
4. Fogelman, A., B. Van Lenten, C. Warden, M. Haberland, and P. Edwards. 1988. Macrophage lipoprotein receptors. J. Cell Sci. (Suppl. 9:) 135-149.
5. Pearson, A., A. Lux, and M. Krieger. 1995. Expression cloning of dSR-Cl, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc. Natl. Acad. Sci. USA. 92: 4056-4060.
6. Elomaa, O., M. Kangas, C. Sahlberg, J. Tuukkanen, R. Sormunen, A. Liakka, I. Thesleff, G. Kraal, and K. Tryggvason. 1995. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell. 80: 603-609.
7. Ramprasad, M., W. Fischer, J. Witztum, G. Sambrano, O. Quehenberger, and D. Steinberg. 1995. The 94-to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of CD68. Proc. Natl. Acad. Sci. USA. 92: 9580-9584.
8. Acton, S., R. Attilio, K. Landschultz, S. Xu, H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science. 271: 518-520.
9. Talle, M. A., P. E. Rao, E. Westberg, N. Allegar, M. Makowski, R. S. Mittler, and G. Goldstein. 1983. Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell Immunol. 78: 83-99.
10. Li, Y. S., Y. J. Shyy, J. G. Wright, A. J. Valente, J. F. Cornhill, and P. E. Kolattukudy. 1993. The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol. Cell Biochem. 126: 61-68.
11. Greenwalt, D., R. Lipsky, C. Ockenhouse, H. Ikeda, N. Tandon, and G. Jamieson. 1992. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood. 80: 1105-1115.
12. Abumrad, N., M. R. El-Maghrabi, E. Amri, E. Lopez, and P. Grimaldi. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J. Biol. Chem. 268: 17665-17668.
13. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis. J. Biol. Chem. 268: 4569-4572.
14. Endemann, G., L. Stanton, K. Madden, K. Bryant, R. T. White, and A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
15. Nicholson, A., S. F. A. Pearce, and R. Silverstein. 1995. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arteriocler. Thromb. 15: 269-275.
16. Rigotti, A., S. Acton, and M. Krieger. 1995. The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270: 16221-16224.
17. Ren, Y., R. Silverstein, J. Allen, and J. Savill. 1995. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181: 1857-1862.
18. Asch, A., J. Barnwell, R. Silverstein, and R. Nachman. 1987. Isolation of the thrombospondin membrane receptor. J. Clin. Invest. 79: 1054-1061.
19. Tandon, N., U. Kralisz, and G. Jamieson. 1989. Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem. 264: 7576-7583.
20. Barnwell, J., C. Ockenhouse, and D. Knowles. 1985. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J. Immunol. 135: 3494-3497.
21. Parthasarathy, S., L. Fong, D. Otero, and D. Steinberg. 1987. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc. Natl. Acad. Sci. USA. 84: 537-540.
22. Calvo, D., D. Gomez-Coronado, Y. Suarez, M. Lasuncion, and M. A. Vega. 1998. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39: 777-788.
23. Pitha, J., T. Irie, P. Sklar, and J. Nye. 1988. Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives. Life Sci. 43: 493-502.
24. Kilsdonk, E. P. C., P. Yancey, G. Stoudt, F. W. Bangerter, W. J. Johnson, M. C. Phillips, and G. H. Rothblat. 1995. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270: 17250-17256.
25. Yancey, P., W. Rodrigueza, E. Kilsdonk, G. W. Stoudt, W. J. Johnson, M. C. Phillips, and G. H. Rothblat. 1996. Cellular cholesterol efflux mediated by cyclodextrins: demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 271: 16026-16034.
26. Christian, A. E., M. P. Haynes, M. Phillips, and G. Rothblat. 1997. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38: 2264-2272.
27. Han, J., D. P. Hajjar, M. Febbraio, and A. C. Nicholson. 1997. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J. Biol. Chem. 272: 21654-21659.
28. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
29. Bilheimer, D., S. Eisenberg, and R. Levy. 1972. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
30. Goldstein, J., S. Basu, and M. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
31. Liao, J. K., W. S. Shin, W. Y. Lee, and S. L. Clark. 1995. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270: 319-324.
32. Ashkenas, J., M. Penman, E. Vasile, S. Acton, M. Freeman, and M. Krieger. 1993. Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J. Lipid Res. 34: 983-1000.
33. Dawson, P., S. Hofmann, D. van de Westhuyzen, T. Sudhof, M. Brown, and J. Goldstein. 1988. Sterol-dependent repression of low density lipoprotein receptor promotor mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J. Biol. Chem. 263: 3372-3379.
34. Yla-Herttuala, S., M. E. Rosenfeld, S. Parthasarathy, E. Sigal, T. Sarkioja, J. L. Witztum, and D. Steinberg. 1991. Gene expression in macrophage-rich human atherosclerotic lesons:15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-proteins adducts. J. Clin. Invest. 87: 1146-1152.
35. Naito, M., H. Suzuki, T. Mori, A, Matsumoto, T. Kodama, and K. Takahashi. 1992. Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am. J. Pathol. 141: 591-599.
36. Williams, K., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561.
37. Han, J., and A. C. Nicholson. 1998. Modulation of macrophage scavenger receptor expression by lipoproteins. Am. J. Pathol. 152: 1647-1654.
38. Yoshida, H., O. Quehenberger, N. Kondratenko, S. Green, and D. Steinberg. 1998. Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler. Thromb. Vasc. Biol. 18: 794-802.
39. Greenwalt, D., S. Scheck, and T. Rhinehart-Jones. 1995. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest. 96: 1380-1388.
40. Pietsch, A., W. Erl, and R. L. Lorenz. 1996. Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. Biochem. Pharmacol. 52: 433-439.
41. Mazzone, T., K. Basheeruddin, and C. Poulos. 1989. Regulation of macrophage apolipoprotein E gene expression by cholesterol. J. Lipid Res. 30: 1055-1063.
42. Harai, A., T. Kino, K. Tokinagra, K. Tahara, Y. Tamura, and S. Yoshida. 1994. Regulation of sterol carrier protein 2 (SCP2) in rat peritoneal macrophages during foam cell development: a key role for free cholesterol content. J. Clin. Invest. 94: 2215-2223.
43. Rogers, K., R. Hoover, J. Castellot, J. Robinson, and M. Karnovsky. 1986. Dietary cholesterol-induced changes in macrophage characteristics. Relationship to atherosclerosis. Am. J. Pathol. 125: 284-291.
44. Fan, J., T. Yamada, O. Tokunaga, and T. Watanabe. 1991. Alterations in the functional characteristics of macrophages induced by hypercholesterolemia. Virchows Arch. B Cell Pathol. 61: 19-27.
45. Montgomery, R., and Z. Cohn. 1989. Endocytic and secretory repertoire of the lipid-loaded macrophage. J. Leukocyte Biol. 45: 129-138.
46. Andalibi, A., F. Liao, S. Imes, A. Fogelman, and A. Lusis. 1993. Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem. Soc. Trans. 21: 651-655.
47. Armesilla, A. L., D. Calvo, and M. A. Vega. 1996. Structural and functional characterization of the human CD36 gene promoter: identification of a proximal PEBP2/CBF site. J. Biol. Chem. 271: 7781-7787.
48. γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93: 241-252.
49. Nagy, L., P. Tontonoz, J. Alvarez, H. Chen, and R. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell. 93: 229-240.